Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn No phase listed Observational

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

ClinicalTrials.gov ID: NCT00510731

Public ClinicalTrials.gov record NCT00510731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 8:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective study to evaluating the ability of the PD2i Cardiac Analyzer to predict the risk of serious heart rhythm abnormalities in high-risk patients that do not already have an Implantable Cardioverter Defibrillator.

Study identification

NCT ID
NCT00510731
Recruitment status
Withdrawn
Study type
Observational
Phase
Not listed
Lead sponsor
Vicor Technologies, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Dec 9, 2015

2006 – 2009

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
VA GLAHS - David Geffen School of Medicine at UCLA Los Angeles California 90073 —
UCLA Medical Center Los Angeles California 90095 —
Cardiovascular Consultants Medical Group San Ramon California 94583 —
Cardiovascular Consultants Medical Group Walnut Creek California 94598 —
St Francis Hospital and Medical Center, Hoffman Heart Institute Hartford Connecticut 06105 —
Jim Moran Heart & Vascular Center Fort Lauderdale Florida 33308 —
Florida Institute for Cardiovascular Care Hollywood Florida 33021 —
Cardiac Disease Specialists Atlanta Georgia 30309 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Massachusetts General Hospital Boston Massachusetts 02215 —
VA Boston Healthcare System West Roxbury Massachusetts 02132 —
Michigan Heart, PC Ypsilanti Michigan 48197 —
Mid America Heart Institute / Saint Luke's Hospital Kansas City Missouri 64111 —
Washington University School of Medicine St Louis Missouri 63110 —
St. Michael's Medical Center Newark New Jersey 07102 —
Good Samaritan Hospital Dayton Ohio 45406 —
Heart Institute of the Cascades Bend Oregon 97701 —
Rhode Island Hospital Providence Rhode Island 02903 —
Medical University of South Carolina Charleston South Carolina 29403 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00510731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2015 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00510731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →